drug · small molecule
bisantrene
Phase 2updated 3mo agoby Racura Oncology Ltd🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Phase 2, with 1 investigational indication.
targets
Alpha-ketoglutarate-dependent dioxygenase FTO
all catalysts(0)
nothing on the calendar yet
Trials studying bisantrene
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1m ago
Found something off?
comments(0)
5-min edit window · permanent after that